Regence prior authorization criteria
Documentation packets and P2P preparation by drug—for prescribers and PA staff. Verify the current member-specific payer criteria and timing before submission.
Regence reviews prior-authorization requests against its published medical policies — diagnosis with ICD-10 code, documented step-therapy history, and prescriber attestation of medical necessity. The applicable product, plan terms, request type, urgency, and governing law determine the decision and appeal clocks. Confirm both in the current member-specific source and denial notice. Criteria by drug appear below.
Prior authorization criteria by drug
Each page covers Regence's submission criteria, the documentation packet, and peer-to-peer prep for that drug.
- Adalimumab at Regence →
- Aflibercept at Regence →
- Apixaban at Regence →
- Atezolizumab at Regence →
- Atogepant at Regence →
- Benralizumab at Regence →
- Bevacizumab at Regence →
- Bictegravir at Regence →
- Buprenorphine at Regence →
- Dapagliflozin at Regence →
- Dulaglutide at Regence →
- Dupilumab at Regence →
- Eculizumab at Regence →
- Elexacaftor Tezacaftor Ivacaftor at Regence →
- Empagliflozin at Regence →
- Erenumab at Regence →
- Evolocumab at Regence →
- Faricimab at Regence →
- Fingolimod at Regence →
- Fremanezumab at Regence →
- Galcanezumab at Regence →
- Glecaprevir Pibrentasvir at Regence →
- Guselkumab at Regence →
- Ibrutinib at Regence →
- Imatinib at Regence →
- Inclisiran at Regence →
- Infliximab at Regence →
- Ixekizumab at Regence →
- Lenalidomide at Regence →
- Liraglutide at Regence →
- Lisdexamfetamine at Regence →
- Mepolizumab at Regence →
- Methylphenidate at Regence →
- Naltrexone at Regence →
- Natalizumab at Regence →
- Nintedanib at Regence →
- Nivolumab at Regence →
- Nusinersen at Regence →
- Ocrelizumab at Regence →
- Ofatumumab at Regence →
- Omalizumab at Regence →
- Ozanimod at Regence →
- Palbociclib at Regence →
- Pembrolizumab at Regence →
- Pirfenidone at Regence →
- Ribociclib at Regence →
- Rimegepant at Regence →
- Risankizumab at Regence →
- Rituximab at Regence →
- Rivaroxaban at Regence →
- Sacubitril Valsartan at Regence →
- Secukinumab at Regence →
- Semaglutide at Regence →
- Sofosbuvir at Regence →
- Tafamidis at Regence →
- Tenofovir Alafenamide at Regence →
- Tezepelumab at Regence →
- Tirzepatide at Regence →
- Tofacitinib at Regence →
- Trastuzumab at Regence →
- Upadacitinib at Regence →
- Ustekinumab at Regence →
Generate a Regence PA packet
Open ApprovalHelp — generate a prior-auth packet tailored to Regence's criteria, with prescriber attestation and step-therapy documentation pre-filled.
Get started →Contact: hello@approvalhelp.com